Lv22
160 积分 2024-01-25 加入
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
1小时前
待确认
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial
1天前
已完结
The optimal cutoffs of liver stiffness measurement for staging fibrosis in on-treatment patients with chronic hepatitis B
16天前
已完结
Lean MASLD in U.S. Adults: Undiagnosed Burden and Metabolic Features from NHANES 2017–2020
17天前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
2个月前
已完结
Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension
5个月前
已完结
皖公网安备34019202002308
